Quavonlimab
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for Quavonlimab, covering 2024-11-18 to 2026-03-30. Get the full timeline:
Most recent: Clinical Trial Update: Evaluation of Co-formulated Pembrolizumab/Quavonlimab (MK-1308A) Versus Other Treatments in Participants With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Stage IV Colorectal Cancer (CRC) (MK-1308A-008/KEYSTEP-008) [Phase 2]